Topic: Non-Practising Entities

Latest content

Oppo, Huawei were most prolific patent challengers in China last year

Exclusive invalidation statistics from IncoPat show the busiest companies on the offensive and the defensive at the CNIPA

25 October 2021

Our 5G licensing rates will be ready before mass vehicle roll-out begins, says top Avanci executive

Senior VP Laurie Fitzgerald was speaking after Swedish truck and bus manufacturer the Volvo Group became the latest licensee of the platform’s 4G programme

20 October 2021

Patent assignment activity of major semiconductor vendors remains robust

Co-published - IP transfers in the sector happen for many reasons but one of the primary ones is to create additional value from the assets concerned

18 October 2021

What we’ve learned from an eventful fortnight in auto IP

Saturday Opinion: Litigation is heating up, big antitrust questions remain unanswered and there’s more to the rising conflict than just wireless SEPs

16 October 2021

Chinese semiconductor upstart steps into IP spotlight in patent licence deal with Xperi

Yangtze Memory Technologies Co, based in Wuhan, is just five years old but has emerged as the country’s memory chip champion

14 October 2021

Why the auto sector is heading for an IP reckoning

The Long Read: Patent figures show the industry has engaged in wholesale borrowing of technology in the connected car era, writes Arvin Patel. Now the bill has become due

13 October 2021

Former Nortel and BlackBerry patents land with smartphone maker Honor

Transaction marks first outside patent acquisition since company was spun out from Huawei last year

13 October 2021

Data indicates Albright is less patentee-friendly than Gilstrap

A comparison between four major US patent venues – EDTX, WDTX, DDE and NDCA – shows the first is best for plaintiffs, the last for defendants

01 October 2021

Fortress beats off Intel’s antitrust claims against its patent aggregation practices

A California judge has dismissed claims that the firm was engaged in anti-competitive conduct

30 September 2021

What patent owners need to know about financing life sciences disputes

The Long Read: Companies in the life sciences sector have increasing options when seeking outside investment in IP enforcement campaigns, writes Michael Gulliford. But unique legal considerations and risk factors call for careful structuring of deals

29 September 2021

Get unlimited access to all IAM content